DexCom, Inc. (DXCM) - Product Pipeline Analysis, 2013 Update

Date: December 31, 2013
Pages: 38
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: D883DF41EECEN
Leaflet:

Download PDF Leaflet

DexCom, Inc. (DXCM) - Product Pipeline Analysis, 2013 Update
Summary

DexCom, Inc. (DexCom) is a medical device company. The company operates in the design, development and selling of continuous glucose monitoring systems for ambulatory. It gained support for its third generation system, the SEVEN PLUS, from the US Food and Drug Administration (FDA). DexCom’s products are for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. The company’s membrane technology has several polymer layers organized for selective permit for the appropriate mix of oxygen and glucose to move through the membrane and react with a glucose specific enzyme. Its ambulatory glucose examining systems use radiofrequency telemetry for wireless broadcast information from the transmitter in a pod atop the sensor till receiver. DexCom small handheld receiver is carried by the patient and wirelessly receives continuous glucose values from the sensor. DexCom is headquartered in San Diego, California, the US.

This report is a source for data, analysis and actionable intelligence on the DexCom, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
DexCom, Inc. - Business Description
Key Facts
DexCom, Inc. - Major Products and Services
DexCom, Inc. Pipeline Products by Equipment Type
DexCom, Inc. Pipeline Products by Development Stage
DexCom, Inc. Pipeline Products by Therapy Area
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR PRODUCT STATUS
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR PRODUCT DESCRIPTION
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR PRODUCT PATENT DETAILS
DexCom Share System
DexCom Share System Product Status
DexCom Share System Product Description
G4 PLATINUM - Pediatric Indication
G4 PLATINUM - Pediatric Indication Product Status
G4 PLATINUM - Pediatric Indication Product Description
G4 Platinum – Advanced Algorithm
G4 Platinum – Advanced Algorithm Product Status
G4 Platinum – Advanced Algorithm Product Description
GlucoClear - Second Generation
GlucoClear - Second Generation Product Status
GlucoClear - Second Generation Product Description
SEVEN PLUS System - Pediatrics
SEVEN PLUS System - Pediatrics Product Status
SEVEN PLUS System - Pediatrics Product Description
SEVEN PLUS System - Pregnancy
SEVEN PLUS System - Pregnancy Product Status
SEVEN PLUS System - Pregnancy Product Description
DexCom, Inc. - Key Competitors
DexCom, Inc. - Key Employees
DexCom, Inc. - Key Employee Biographies
DexCom, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
DexCom, Inc., Recent Developments
Nov 21, 2013: DexCom Announces Upcoming Conference Presentations
Nov 06, 2013: DexCom Announces Appointment of Steve Altman as Board Member
Nov 06, 2013: DexCom Reports Third Quarter 2013 Financial Results
Nov 01, 2013: DexCom Announces Upcoming Conference Presentations
Oct 23, 2013: DexCom Schedules Third Quarter 2013 Earnings Release and Conference Call for November 6, 2013 at 4:30 p.m. Eastern Time
Aug 07, 2013: DexCom Reports Second Quarter 2013 Financial Results
Jul 31, 2013: DexCom to Present at Canaccord Genuity 33rd Annual Growth Conference
Jul 25, 2013: DexCom Schedules Second Quarter 2013 Earnings Release and Conference Call for August 7, 2013 at 4:30 p.m. Eastern Time
May 01, 2013: DexCom Inc. Reports First Quarter 2013 Financial Results
Feb 21, 2013: DexCom Reports Revenue Of $99.9m In 2012
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

DexCom, Inc., Key Facts
DexCom, Inc. Key Pipeline Products by Equipment Type
DexCom, Inc. Key Pipeline Products by Therapy Area
DexCom, Inc. Key Pipeline Products by Development Stage
DexCom, Inc., Key Facts
DexCom, Inc., Major Products and Services
DexCom, Inc. Number of Pipeline Products by Equipment Type
DexCom, Inc. Pipeline Products by Equipment Type
DexCom, Inc. Number of Pipeline Products by Development Stage
DexCom, Inc. Pipeline Products by Development Stage
DexCom, Inc. Number of Pipeline Products by Therapy Area
DexCom, Inc. Pipeline Products by Therapy Area
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PRODUCT STATUS
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PRODUCT DESCRIPTION
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS1
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS2
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS3
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS4
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS5
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS6
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS7
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS8
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS9
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS10
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS11
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS12
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS13
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS14
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS15
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS16
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PATENT DETAILS17
DexCom Share System - Product Status
DexCom Share System - Product Description
G4 PLATINUM - Pediatric Indication - Product Status
G4 PLATINUM - Pediatric Indication - Product Description
G4 Platinum – Advanced Algorithm - Product Status
G4 Platinum – Advanced Algorithm - Product Description
GlucoClear - Second Generation - Product Status
GlucoClear - Second Generation - Product Description
SEVEN PLUS System - Pediatrics - Product Status
SEVEN PLUS System - Pediatrics - Product Description
SEVEN PLUS System - Pregnancy - Product Status
SEVEN PLUS System - Pregnancy - Product Description
DexCom, Inc., Key Employees
DexCom, Inc., Key Employee Biographies
DexCom, Inc., Subsidiaries

LIST OF FIGURES

DexCom, Inc. Pipeline Products by Equipment Type
DexCom, Inc. Pipeline Products by Development Stage
DexCom, Inc. Pipeline Products by Therapy Area

Ask Your Question

DexCom, Inc. (DXCM) - Product Pipeline Analysis, 2013 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: